Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Vs VMP in NDMM Pts (ALCYONE)

Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) ... Author: InternationalMyelomaFoundation Added: 01/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts